{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:14:35Z","timestamp":1789074875796,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008331","name":"Universidade Federal Do Rio De Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GB) is the most aggressive and lethal primary brain tumor, characterized by high proliferative, migratory, and invasive capacities, as well as marked resistance to apoptosis. Despite standard therapy with temozolomide (TMZ), prognosis remains poor, underscoring the need for novel therapeutic strategies. In this study, we investigated the antitumor potential of centratherin, a sesquiterpene lactone, in established GB cell lines and patient-derived GB cells (GBM02, GBM95). Centratherin significantly reduced cell viability in a dose-dependent manner, with IC50 values varying across GB cells, while exhibiting no cytotoxicity to healthy human astrocytes. Functional assays revealed that centratherin impairs cell proliferation, migration, and invasion, and alters cytoskeletal architecture, as evidenced by morphological changes, reduced actin and tubulin organization. Additionally, centratherin induced double-strand DNA breaks, increased \u03b3H2AX levels, and triggered cell death predominantly via necrosis, as demonstrated by LIVE\/DEAD staining, Annexin V\/PI flow cytometry, and ultrastructural analysis. Notably, this cytotoxic effect did not involve necroptosis, as RIP1 expression and Nec-1 sensitivity were unchanged. Furthermore, centratherin failed to sensitize GB cells to TMZ, suggesting distinct mechanisms of action, in spite of its remarked effect on inducing cell death in GB cancer stem-like cells. Overall, our findings highlight centratherin as a promising selective cytotoxic agent against GB, capable of inducing cell death and disrupting key malignant phenotypes, which may be advantageous for GB treatment.<\/jats:p>","DOI":"10.1007\/s11064-025-04659-6","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:58:03Z","timestamp":1770458283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Centratherin Exhibits Antitumor Activity Against Glioblastoma Cells"],"prefix":"10.1007","volume":"51","author":[{"given":"Bruna","family":"Mafra de Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Leme da Silva Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathas F. R.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Magno","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Machado Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel Doria","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loraine Campanati","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gustavo","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Ferreira","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"4659_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol 20:1\u201386. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"4659_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"4659_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-0038-1636536","volume":"38","author":"ZJ Reitman","year":"2018","unstructured":"Reitman ZJ, Winkler F, Elia AEH (2018) New directions in the treatment of glioblastoma. Semin Neurol 38:50\u201361. https:\/\/doi.org\/10.1055\/s-0038-1636536","journal-title":"Semin Neurol"},{"key":"4659_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-021-02220-4","volume":"141","author":"DN Louis","year":"2021","unstructured":"Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Acta Neuropathol 141:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-021-02220-4","journal-title":"Acta Neuropathol"},{"key":"4659_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-135","volume":"9","author":"C Krakstad","year":"2010","unstructured":"Krakstad C, Chekenya M (2010) Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9:135. https:\/\/doi.org\/10.1186\/1476-4598-9-135","journal-title":"Mol Cancer"},{"key":"4659_CR6","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/S0968-0896(99)00182-6","volume":"7","author":"P R\u00fcngeler","year":"1999","unstructured":"R\u00fcngeler P et al (1999) Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem 7:2343\u20132352. https:\/\/doi.org\/10.1016\/S0968-0896(99)00182-6","journal-title":"Bioorg Med Chem"},{"key":"4659_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bcp.2010.10.015","volume":"81","author":"A Zanotto-Filho","year":"2011","unstructured":"Zanotto-Filho A et al (2011) NFkB inhibitors induce cell death in glioblastomas. Biochem Pharmacol 81:412\u2013424. https:\/\/doi.org\/10.1016\/j.bcp.2010.10.015","journal-title":"Biochem Pharmacol"},{"key":"4659_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/neuonc\/nor190","volume":"14","author":"T Fukushima","year":"2012","unstructured":"Fukushima T et al (2012) Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-kB, on glioblastoma. Neuro Oncol 14:19\u201328. https:\/\/doi.org\/10.1093\/neuonc\/nor190","journal-title":"Neuro Oncol"},{"key":"4659_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0031-9422(00)84205-0","volume":"18","author":"N Ohno","year":"1979","unstructured":"Ohno N, McCormick S, Mabry TJ (1979) Centratherin, a new germacranolide from Centratherum punctatum. Phytochemistry 18:681\u2013682. https:\/\/doi.org\/10.1016\/S0031-9422(00)84205-0","journal-title":"Phytochemistry"},{"key":"4659_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1055\/s-2006-951698","volume":"72","author":"N Vongvanich","year":"2006","unstructured":"Vongvanich N et al (2006) Antiplasmodial, antimycobacterial, and cytotoxic principles from Camchaya calcarea. Planta Med 72:1427\u20131430. https:\/\/doi.org\/10.1055\/s-2006-951698","journal-title":"Planta Med"},{"key":"4659_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1590\/S0102-695X2012005000131","volume":"22","author":"JFR Lobo","year":"2012","unstructured":"Lobo JFR et al (2012) Antiproliferative activity of Eremanthus crotonoides extracts and centratherin demonstrated in brain tumor cell lines. Braz J Pharmacogn 22:1295\u20131300. https:\/\/doi.org\/10.1590\/S0102-695X2012005000131","journal-title":"Braz J Pharmacogn"},{"key":"4659_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2024.134112","volume":"162","author":"PHR de Oliveira","year":"2024","unstructured":"de Oliveira PHR et al (2024) Novel centratherin derivatives: molecular docking design, asymmetric synthesis, and antitumoral activity. Tetrahedron 162:134112. https:\/\/doi.org\/10.1016\/j.tet.2024.134112","journal-title":"Tetrahedron"},{"issue":"12","key":"4659_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121623","volume":"17","author":"VS de S\u00e3o Jos\u00e9","year":"2024","unstructured":"de S\u00e3o Jos\u00e9 VS et al (2024) Repurposing osimertinib and gedatolisib for glioblastoma treatment: evidence of synergistic effects in an in vitro phenotypic study. Pharmaceuticals 17(12):1623. https:\/\/doi.org\/10.3390\/ph17121623","journal-title":"Pharmaceuticals"},{"issue":"13","key":"4659_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136392","volume":"26","author":"VS de S\u00e3o Jos\u00e9","year":"2025","unstructured":"de S\u00e3o Jos\u00e9 VS et al (2025) A pharmacologic approach against glioblastoma-a synergistic combination of a quinoxaline-based and a PI3K\/mTOR dual inhibitor. Int J Mol Sci 26(13):6392. https:\/\/doi.org\/10.3390\/ijms26136392","journal-title":"Int J Mol Sci"},{"key":"4659_CR15","doi-asserted-by":"publisher","first-page":"41432","DOI":"10.1074\/jbc.M112.380824","volume":"287","author":"LP Diniz","year":"2012","unstructured":"Diniz LP et al (2012) Astrocyte-induced synaptogenesis is mediated by transforming growth factor \u03b2 signaling through modulation of d-serine levels in cerebral cortex neurons. J Biol Chem 287:41432\u201341445. https:\/\/doi.org\/10.1074\/jbc.M112.380824","journal-title":"J Biol Chem"},{"key":"4659_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1432-0436.2006.00082.x","volume":"74","author":"J Faria","year":"2006","unstructured":"Faria J et al (2006) Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 74:562\u2013572. https:\/\/doi.org\/10.1111\/j.1432-0436.2006.00082.x","journal-title":"Differentiation"},{"key":"4659_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bioorg.2018.10.003","volume":"83","author":"VD Silva","year":"2019","unstructured":"Silva VD et al (2019) Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells. Bioorg Chem 83:87\u201397.https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.003","journal-title":"Bioorg Chem"},{"key":"4659_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/dneu.20732","volume":"69","author":"M Marins","year":"2009","unstructured":"Marins M et al (2009) Gap junctions are involved in cell migration in the early postnatal subventricular zone. Dev Neurobiol 69:715\u2013730. https:\/\/doi.org\/10.1002\/dneu.20732","journal-title":"Dev Neurobiol"},{"key":"4659_CR19","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.2174\/156802612805289978","volume":"12","author":"SA Kahn","year":"2012","unstructured":"Kahn SA et al (2012) Equinatoxin II potentiates temozolamide- and etoposide-induced glioblastoma cell death. Curr Top Med Chem 12:2082\u20132093. https:\/\/doi.org\/10.2174\/156802612805289978","journal-title":"Curr Top Med Chem"},{"key":"4659_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000000581","volume":"29","author":"L Rom\u00e3o","year":"2018","unstructured":"Rom\u00e3o L et al (2018) Conjugation with polyamines enhances the antitumor activity of naphthoquinones against human glioblastoma cells. Anticancer Drugs 29:1\u201310. https:\/\/doi.org\/10.1097\/CAD.0000000000000581","journal-title":"Anticancer Drugs"},{"key":"4659_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbagen.2014.01.025","volume":"1850","author":"J Bal\u00e7a-Silva","year":"2014","unstructured":"Bal\u00e7a-Silva J et al (2014) Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines. Biochim Biophys Acta 1850:722\u2013732. https:\/\/doi.org\/10.1016\/j.bbagen.2014.01.025","journal-title":"Biochim Biophys Acta"},{"key":"4659_CR22","doi-asserted-by":"publisher","first-page":"5.7.1","DOI":"10.1002\/cpcy.30","volume":"119","author":"Z Darzynkiewicz","year":"2017","unstructured":"Darzynkiewicz Z, Huang X, Zhao H (2017) Analysis of cellular DNA content by flow cytometry. Curr Protoc Cytom 119:5.7.1-5.7.20. https:\/\/doi.org\/10.1002\/cpcy.30","journal-title":"Curr Protoc Cytom"},{"key":"4659_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nprot.2014.024","volume":"9","author":"A Boudaoud","year":"2014","unstructured":"Boudaoud A et al (2014) FibrilTool, an ImageJ plug-in to quantify fibrillar structures in raw microscopy images. Nat Protoc 9:457\u2013463. https:\/\/doi.org\/10.1038\/nprot.2014.024","journal-title":"Nat Protoc"},{"key":"4659_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s13402-017-0319-7","volume":"40","author":"D Matias","year":"2017","unstructured":"Matias D et al (2017) Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell Oncol 40:247\u2013261. https:\/\/doi.org\/10.1007\/s13402-017-0319-7","journal-title":"Cell Oncol"},{"key":"4659_CR25","first-page":"255","volume":"34","author":"D Wlockowic","year":"2012","unstructured":"Wlockowic D, Skommer J, Darzynkiewicz Z (2012) Cytometry of apoptosis: historical perspective and new advances. Exp Oncol 34:255\u2013262","journal-title":"Exp Oncol"},{"key":"4659_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1017\/S1740925X06000212","volume":"2","author":"EM Caspani","year":"2006","unstructured":"Caspani EM et al (2006) Live imaging of glioblastoma cells in brain tissue shows requirement of actin bundles for migration. Neuron Glia Biol 2:105\u2013114. https:\/\/doi.org\/10.1017\/S1740925X06000212","journal-title":"Neuron Glia Biol"},{"key":"4659_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/mt.2012.34","volume":"20","author":"R Berges","year":"2012","unstructured":"Berges R et al (2012) A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis. Mol Ther 20:1367\u20131377. https:\/\/doi.org\/10.1038\/mt.2012.34","journal-title":"Mol Ther"},{"key":"4659_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/cancers11040511","volume":"11","author":"MO Nowicki","year":"2019","unstructured":"Nowicki MO et al (2019) Proteomic analysis implicates vimentin in glioblastoma cell migration. Cancers 11:511. https:\/\/doi.org\/10.3390\/cancers11040511","journal-title":"Cancers"},{"key":"4659_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-319-57127-0_7","volume":"1002","author":"M Gotta","year":"2017","unstructured":"Gotta M, Meraldi P (2017) Cell division machinery and disease. Adv Exp Med Biol 1002:125\u2013152. https:\/\/doi.org\/10.1007\/978-3-319-57127-0_7","journal-title":"Adv Exp Med Biol"},{"key":"4659_CR30","doi-asserted-by":"publisher","first-page":"9484","DOI":"10.1038\/s41598-018-27790-x","volume":"8","author":"S Desir","year":"2018","unstructured":"Desir S et al (2018) Chemotherapy-induced tunneling nanotubes mediate intercellular drug efflux in pancreatic cancer. Sci Rep 8:9484. https:\/\/doi.org\/10.1038\/s41598-018-27790-x","journal-title":"Sci Rep"},{"key":"4659_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ymeth.2013.01.002","volume":"61","author":"T Vanden Berghe","year":"2013","unstructured":"Vanden Berghe T et al (2013) Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods 61:117\u2013129. https:\/\/doi.org\/10.1016\/j.ymeth.2013.01.002","journal-title":"Methods"},{"key":"4659_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cr.2015.149","volume":"26","author":"S Matt","year":"2016","unstructured":"Matt S, Hofmann TG (2016) DNA damage-induced cell death: lessons from the central nervous system. Cell Res 26:1\u201318. https:\/\/doi.org\/10.1038\/cr.2015.149","journal-title":"Cell Res"},{"key":"4659_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1308573","journal-title":"N Engl J Med"},{"key":"4659_CR34","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"key":"4659_CR35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/carcin\/bgy107","volume":"39","author":"D Garnier","year":"2018","unstructured":"Garnier D et al (2018) Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. Carcinogenesis 39:1205\u20131213. https:\/\/doi.org\/10.1093\/carcin\/bgy107","journal-title":"Carcinogenesis"},{"issue":"4","key":"4659_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tranon.2017.04.005","volume":"10","author":"J Bal\u00e7a-Silva","year":"2017","unstructured":"Bal\u00e7a-Silva J et al (2017) The expression of connexins and SOX2 reflects the plasticity of glioma stem-like cells. Transl Oncol 10(4):555\u2013569. https:\/\/doi.org\/10.1016\/j.tranon.2017.04.005","journal-title":"Transl Oncol"},{"key":"4659_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093133","author":"V Desai","year":"2017","unstructured":"Desai V and Bhushan A (2017) Natural bioactive compounds: alternative approach to the treatment of glioblastoma multiforme. BioMed Res Int. https:\/\/doi.org\/10.1155\/2017\/9363040","journal-title":"BioMed Res Int"},{"key":"4659_CR38","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ptr.6170","volume":"32","author":"JI Erices","year":"2018","unstructured":"Erices JI et al (2018) Current natural therapies in the treatment against glioblastoma. Phytother Res32:2191\u20132201. https:\/\/doi.org\/10.1002\/ptr.6170","journal-title":"Phytother Res"},{"key":"4659_CR39","first-page":"1270","volume":"7","author":"J >Wang","year":"2017","unstructured":"Wang J et al (2017) Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma through inhibition of the NF-\u03baB\/COX-2 signaling pathway by targeting IKK\u03b2. Am J Cancer Res 7:1270\u20131284.","journal-title":"Am J Cancer Res"},{"key":"4659_CR40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/ptr.3693","volume":"26","author":"RL Strapasson","year":"2012","unstructured":"Strapasson RL et al (2012) Bioactivity-guided isolation of cytotoxic sesquiterpene lactones of Gochnatia polymorpha ssp. floccosa. Phytother Res 26:1053\u20131056. https:\/\/doi.org\/10.1002\/ptr.3693","journal-title":"Phytother Res"},{"key":"4659_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/aps.2012.137","volume":"34","author":"SS Liu","year":"2013","unstructured":"Liu SS et al (2013) 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2\/M arrest and apoptosis of human glioblastoma cells in vitro. Acta Pharmacol Sin 34:271\u2013281. https:\/\/doi.org\/10.1038\/aps.2012.137","journal-title":"Acta Pharmacol Sin"},{"key":"4659_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mrgentox.2013.06.010","volume":"756","author":"PR Godoy","year":"2013","unstructured":"Godoy PR et al (2013) Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines. Mutat Res Genet Toxicol Environ Mutagen 756:46\u201355. https:\/\/doi.org\/10.1016\/j.mrgentox.2013.06.010","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"4659_CR43","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1038\/cddis.2013.283","volume":"4","author":"D Biasoli","year":"2004","unstructured":"Biasoli D et al (2013) Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis and favors glioblastoma resistance to etoposide. Cell Death & Disease4:e767. https:\/\/doi.org\/10.1038\/cddis.2013.283","journal-title":"Cell Death & Disease"},{"key":"4659_CR44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom A et al (2004) Nanotubular highways for intercellular organelle transport. Science 303:1007\u20131010. https:\/\/doi.org\/10.1126\/science.1093133","journal-title":"Science"},{"key":"4659_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/cdd.2014.211","volume":"22","author":"X Wang","year":"2015","unstructured":"Wang X, Gerdes HH (2015) Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ 22:1181\u20131191. https:\/\/doi.org\/10.1038\/cdd.2014.211","journal-title":"Cell Death Differ"},{"key":"4659_CR46","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1038\/sj.onc.1207097","volume":"22","author":"MC Seminario","year":"2003","unstructured":"Seminario MC et al (2003) PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression. Oncogene 22:8195\u20138204. https:\/\/doi.org\/10.1038\/sj.onc.1207097","journal-title":"Oncogene"},{"key":"4659_CR47","first-page":"493","volume":"1","author":"J Wightman","year":"2002","unstructured":"Wightman J et al (2002) Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle. Mol Cancer Ther 1:493\u2013506","journal-title":"Mol Cancer Ther"},{"key":"4659_CR48","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3892\/ijmm.2015.2369","volume":"36","author":"E Blahovcova","year":"2015","unstructured":"Blahovcova E et al (2015) Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme. Int J Mol Med 36:1677\u20131684.https:\/\/doi.org\/10.3892\/ijmm.2015.2369","journal-title":"Int J Mol Med"},{"key":"4659_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jnnp.67.6.763","volume":"67","author":"H Strik","year":"1999","unstructured":"Strik H et al (1999) BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry 67:763\u2013768. https:\/\/doi.org\/10.1136\/jnnp.67.6.763","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4659_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118791","volume":"10","author":"N Bailon-Moscoso","year":"2015","unstructured":"Bailon-Moscoso N et al (2015) Phytometabolite dehydroleucodine induces cell cycle arrest, apoptosis, and DNA damage in human astrocytoma cells through p73\/p53 regulation. PLoS ONE 10:e0118791. https:\/\/doi.org\/10.1371\/journal.pone.0118791","journal-title":"PLoS ONE"},{"key":"4659_CR51","doi-asserted-by":"publisher","first-page":"67235","DOI":"10.18632\/oncotarget.11563","volume":"7","author":"N Berte","year":"2016","unstructured":"Berte N et al (2016) Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence. Oncotarget 7:67235\u201367250. https:\/\/doi.org\/10.18632\/oncotarget.11563","journal-title":"Oncotarget"},{"key":"4659_CR52","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L et al (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4","journal-title":"Cell Death Differ"},{"key":"4659_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2015.11.036","volume":"371","author":"D Ma","year":"2016","unstructured":"Ma D et al (2016) Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS. Cancer Lett 371:194\u2013204. https:\/\/doi.org\/10.1016\/j.canlet.2015.11.036","journal-title":"Cancer Lett"},{"key":"4659_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mnfr.201400181","volume":"58","author":"CC Lu","year":"2014","unstructured":"Lu CC et al (2014) Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline. Mol Nutr Food Res 58:1\u201311. https:\/\/doi.org\/10.1002\/mnfr.201400181","journal-title":"Mol Nutr Food Res"},{"key":"4659_CR55","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3892\/or.2012.1733","volume":"27","author":"H Huang","year":"2012","unstructured":"Huang H et al (2012) Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-\u03baB-dependent pathway. Oncol Rep 27:2050\u20132056. https:\/\/doi.org\/10.3892\/or.2012.1733","journal-title":"Oncol Rep"},{"key":"4659_CR56","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/aps.2014.17","volume":"35","author":"D Sang","year":"2014","unstructured":"Sang D, Li R, Lan Q (2014) Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta Pharmacol Sin 35:832\u2013838. https:\/\/doi.org\/10.1038\/aps.2014.17","journal-title":"Acta Pharmacol Sin"},{"key":"4659_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canlet.2018.04.028","volume":"428","author":"Z Yu","year":"2018","unstructured":"Yu Z et al (2018) Inhibition of NF-\u03baB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Cancer Lett 428:77\u201389. https:\/\/doi.org\/10.1016\/j.canlet.2018.04.028","journal-title":"Cancer Lett"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04659-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:12:20Z","timestamp":1772619140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04659-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4659"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04659-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}